ACADIA Pharmaceuticals (ACAD) director receives new RSUs and stock option grant
Rhea-AI Filing Summary
ACADIA Pharmaceuticals director Edmund Harrigan reported compensation-related equity activity, not open-market trading. On May 29, 2026, he exercised restricted stock units into 8,107 shares of common stock, bringing his direct common stock holdings to 43,148 shares.
He also received new awards on the same date: 9,311 restricted stock units, each representing a right to one share of common stock, and 16,004 director stock options with a $21.66 exercise price expiring on May 28, 2036. The new RSUs and options vest over roughly one year or until the next annual stockholders’ meeting, aligning his compensation with shareholder outcomes.
Positive
- None.
Negative
- None.
Insider Trade Summary
8,107 shares exercised/converted
Mixed
4 txns
Insider
HARRIGAN EDMUND
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 8,107 | $0.00 | -- |
| Grant/Award | Director Stock Options (Right to Buy) | 16,004 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 9,311 | $0.00 | -- |
| Exercise | Common Stock | 8,107 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct);
Director Stock Options (Right to Buy) — 16,004 shares (Direct);
Common Stock — 43,148 shares (Direct)
Footnotes (1)
- Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. The restricted stock units vested in full on May 29, 2026, the date on which an annual meeting of stockholders was held. The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders. The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders.
Key Figures
RSUs exercised into common stock: 8,107 shares
Common shares held after transactions: 43,148 shares
New restricted stock units granted: 9,311 RSUs
+3 more
6 metrics
RSUs exercised into common stock
8,107 shares
Restricted stock units converted to common on May 29, 2026
Common shares held after transactions
43,148 shares
Direct common stock holdings following May 29, 2026 activity
New restricted stock units granted
9,311 RSUs
Each RSU represents a right to one common share
New director stock options granted
16,004 options
Options on common stock granted May 29, 2026
Option exercise price
$21.66 per share
Conversion or exercise price for new director stock options
Option expiration date
May 28, 2036
Expiration of newly granted director stock options
Key Terms
Restricted Stock Units, Director Stock Options (Right to Buy), vested in full, vest quarterly, +1 more
5 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Director Stock Options (Right to Buy) financial
"Director Stock Options (Right to Buy) with an exercise price of 21.6600."
vested in full financial
"The restricted stock units vested in full on May 29, 2026, the date on which an annual meeting of stockholders was held."
vest quarterly financial
"The shares subject to each stock option will vest quarterly over one year following the date of grant."
annual meeting of stockholders financial
"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did ACAD director Edmund Harrigan report?
Edmund Harrigan reported equity compensation activity, not market trading. He exercised 8,107 restricted stock units into common stock and received new grants of 9,311 restricted stock units and 16,004 stock options, all tied to his role as a director.
What equity awards did the ACAD director receive on May 29, 2026?
On May 29, 2026, the director received 9,311 restricted stock units and 16,004 director stock options. Each restricted stock unit represents a right to one ACADIA common share, and each option allows purchase of one share at a $21.66 exercise price.
What are the vesting terms of the new ACAD restricted stock units and options?
The new restricted stock units vest in full on the earlier of one year from grant or the next annual stockholders’ meeting. The new stock options vest quarterly over one year on the same schedule, aligning vesting with ongoing board service.
What is the exercise price and expiration date of the new ACAD director stock options?
The newly granted director stock options have a $21.66 exercise price per share and expire on May 28, 2036. They vest in quarterly installments over the year following grant, or sooner if the next annual stockholders’ meeting occurs earlier.